When the Regulator Sets Prices That the Market Could Not Alone
The UK Competition and Markets Authority (CMA) has just issued an order that, in another context, might sound routine: veterinary clinics must publicly display price lists, limit written prescription fees to a maximum of £21, and a cost comparison website will soon operate, allowing pet owners to evaluate their options before spending money. The news was accompanied by a phrase that is more telling than any statistic: "It feels like they're pulling numbers out of thin air," said a pet owner quoted by The Guardian. This phrase does not describe a perception; it describes a business model.
What just happened in the UK veterinary market is a textbook case of how an industry can lose consumer trust without committing any illegality. For SMEs in the animal health sector—most of which are not large corporations but independent practices with three employees and a stainless steel table—the consequences of this new regulatory framework are much more complex than the media coverage suggests.
Opacity in Pricing as an Unintentional Business Model
For years, the veterinary sector operated under a logic more akin to high-end dining than to medicine: the price did not exist until the invoice arrived. There was no menu. No published fee. The emergency consultation, the X-ray, the branded antibiotic, the fee for writing a prescription so the owner could purchase the drug cheaper online—everything was summed up in a document the client saw for the first time at the time of payment.
This did not require bad faith. It simply required a lack of real competitive pressure. When a dog is sick at eleven o'clock at night, the owner is not shopping around for prices: they are seeking urgent emotional relief. In that context, the veterinarian does not compete with other veterinarians because the choice has already been made before the client stepped through the door. The market, technically, was functioning. But it was functioning with its back to the consumer.
The CMA identified precisely that: a structure where asymmetric information was not a byproduct but the central mechanism of price setting. And the regulatory response—publishing fees, limiting prescription costs, launching a cost comparison site—targets that mechanism directly. The £21 cap on written prescriptions is not arbitrary: it acknowledges that this document, which has a near-zero marginal cost to produce, had become an undue income lever.
What This Costs a Small Clinic
Here is where the analysis becomes complicated because the narrative of "regulator protecting the consumer from the industry" flattens a much more nuanced reality. The UK veterinary market is not solely dominated by large, consolidated groups. There are thousands of independent clinics whose economics rely on tight margins, expensive commercial leases, slow-depreciating medical equipment, and highly specialized staff with commensurate salaries.
For these SMEs, the obligation to publish prices is not merely a communication shift but a competitive exposure for which many are unprepared. Publishing prices means the cost comparator the CMA will launch will place them in a table alongside their competitors. The clinic that has built its advantage over years through neighborhood trust, long-term client relationships, and accumulated knowledge of each animal's medical history will see that advantage eroded by a price-per-consultation filter.
The specific risk is the one that occurs in any market where price comparability is introduced without quality comparability: the consumer, rationally, chooses the lowest number. The clinic that invested in advanced diagnostic equipment, ongoing training, and extended hours will compete in the same spreadsheet cell as one that did not. This does not invalidate the regulatory measure. But it forces independent operators to rethink how they communicate the value they provide beyond price.
The Comparator as a Catalyst, Not a Solution
The CMA's decision to launch a cost comparison site deserves separate analysis because comparators have a mixed track record as market correction instruments. In the UK insurance sector, platforms like Comparethemarket and GoCompare succeeded in pushing prices down and increasing transparency. But they also created a known effect: providers optimize their offerings to win the comparator’s algorithm, not to better serve the customer. Prices drop, service quality stagnates or worsens, and the consumer ends up with a cheaper policy that does not cover what they need.
In the veterinary sector, that risk is amplified because the quality of an animal medical consultation is extraordinarily difficult to codify in a text field. A comparator can show that the initial consultation costs £45 at clinic A and £68 at clinic B. It cannot show that clinic B has a feline cardiology specialist who will prevent three unnecessary follow-up consultations. The platform will compare prices; the client will continue buying something they cannot fully evaluate until after consuming it.
For SMEs in the sector, this opens a precise strategic window: the moment the market becomes price comparable is exactly when differentiation in experience, communication, and documented clinical outcomes becomes more valuable, not less. Clinics that understand this sooner will have an advantage. Those that respond by lowering prices to gain a position in the comparator will likely sacrifice margins without building lasting loyalty.
The Work a Pet Owner is Hiring
The phrase from the pet owner quoted by The Guardian—that feeling that numbers come from thin air—accurately reveals the work this consumer was attempting to hire and couldn’t. They were not buying a veterinary consultation. They were buying certainty: the certainty that cost was proportional to service, that they were not being treated as someone without options, that there was some comprehensible order behind the bill.
The success or failure of this new regulatory framework will not depend on whether the £21 cap is the correct number, nor on whether the comparator generates sufficient traffic. It will depend on whether veterinary clinics—especially independents—understand that the work their customer is hiring is not animal healthcare: it is peace of mind in a moment of emotional vulnerability. Price transparency is merely the minimum requirement to compete on that terrain. Differentiation will come from those who can make that peace of mind deliverable, measurable, and repeatable, with or without a regulator demanding it.
